Volume | 440,523 |
|
|||||
News | - | ||||||
Day High | 6.20 | Low High |
|||||
Day Low | 4.4401 |
Share Name | Share Symbol | Market | Stock Type |
---|---|---|---|
ZyVersa Therapeutics Inc | ZVSA | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
5.49 | 4.4401 | 6.20 | 4.99 | 6.075 |
Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
---|---|---|---|---|---|
29,087 | 440,523 | US$ 4.96 | US$ 2,184,244 | - | 0.50 - 22.085 |
Last Trade | Type | Quantity | Price | Currency |
---|---|---|---|---|
18:59:46 | 1 | US$ 4.8608 | USD |
ZyVersa Therapeutics Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
27.97M | 1.24M | - | 0 | -106.25M | -85.46 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
ZyVersa Therapeutics News
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ZVSA Price Data
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 0.64 | 6.20 | 0.55 | 0.5930973 | 286,533 | 4.23 | 660.94% |
1 Month | 0.75 | 6.20 | 0.55 | 0.6716929 | 314,953 | 4.12 | 549.33% |
3 Months | 0.59 | 6.20 | 0.54 | 0.9947317 | 2,638,317 | 4.28 | 725.42% |
6 Months | 3.92 | 6.20 | 0.50 | 1.86 | 2,882,439 | 0.95 | 24.23% |
1 Year | 17.997 | 22.085 | 0.50 | 5.38 | 3,458,995 | -13.13 | -72.94% |
3 Years | 490.00 | 523.25 | 0.50 | 8.88 | 2,638,499 | -485.13 | -99.01% |
5 Years | 490.00 | 523.25 | 0.50 | 8.88 | 2,638,499 | -485.13 | -99.01% |
ZyVersa Therapeutics Description
ZyVersa Therapeutics Inc is a clinical stage specialty biopharmaceutical company that leverages advanced proprietary technologies to develop and commercialize first-in-class prescription drugs. The company's focus is on restoring health and improving quality of life for patients with high unmet medical needs, with emphasis on inflammatory and renal diseases. |